Tag: ASX

May 18, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 11, 2018

Notes from the Floor: Mines and Money New York

If you missed Mines and Money New York, don't worry — we've put together a pictorial overview of what happened...
May 9, 2018

Copper Production Heats Up in Chile

Copper powerhouse Chile saw production increase by 18.9 percent in Q1 2018 over the same time last year, according to...
May 9, 2018

Triton Minerals Signs Second Graphite Offtake Deal for Ancuabe

The graphite developer has agreed to sell up to 16,000 tonnes per year of graphite concentrate from the mine to...
May 9, 2018

Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider

Medibio (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced the execution of a commercial contract with St. John of...
May 8, 2018

MMG’s Dugald River Zinc Mine Achieves Commercial Production

Australian base metals miner MMG announced this week that its Dugald River zinc mine in northern Queensland had achieved commercial...
May 8, 2018

Black Rock Produces Ultrahigh-grade Graphite Concentrate

Australian-based Black Rock Mining has produced what it believes is the world’s first 99.3 percent purity graphite concentrate at its...
May 8, 2018

Heron’s G2 Lens Delivers Strong Metallurgical Results

Heron Resources has reported results from a metallurgical test work program undertaken on the shallow G2 Lens at its Woodlawn...
May 8, 2018

Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program

Immuron (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the...